IVI begins enrollment for Phase 3 efficacy trial of COVID-19 vaccine candidates in Nepal
The International Vaccine Institute (IVI), an international organization dedicated to the discovery, development and delivery of safe, effective and affordable vaccines, will conduct the Phase 3 clinical trial in Nepal, expecting to enroll 4,000 volunteers across 3 study sites in the country. Sanofi and GSK received approval for their Phase 3 clinical study in Nepal […]
IVI begins enrollment for Phase 3 efficacy trial of COVID-19 vaccine candidates in Nepal Read Post »